BTG-1640

We are open as normal during COVID-19 pandemic. Order online, same day shipping out.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530311

CAS#: 152538-59-5

Description: BTG-1640, also known as ABIO-0801; SP-1640; ABIO-08-01, a drug potentially for the treatment of anxiety and panic disorder.


Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-03-30. Prices are subject to change without notice.

BTG-1640 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 530311
Name: BTG-1640
CAS#: 152538-59-5
Chemical Formula: C15H19NO2
Exact Mass: 245.1416
Molecular Weight: 245.322
Elemental Analysis: C, 73.44; H, 7.81; N, 5.71; O, 13.04


Synonym: BTG-1640; BTG 1640; BTG1640; ABIO-0801; SP-1640; ABIO-08-01.

IUPAC/Chemical Name: (3S,3aR,7aR)-3-benzyl-2-methylhexahydrobenzo[d]isoxazol-4(2H)-one

InChi Key: ALQXIMVNPRVWQA-CFVMTHIKSA-N

InChi Code: InChI=1S/C15H19NO2/c1-16-12(10-11-6-3-2-4-7-11)15-13(17)8-5-9-14(15)18-16/h2-4,6-7,12,14-15H,5,8-10H2,1H3/t12-,14+,15-/m0/s1

SMILES Code: O=C1[C@]2([H])[C@H](CC3=CC=CC=C3)N(C)O[C@]2([H])CCC1


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Saletu B, Anderer P, Wolzt M, Nosiska D, Assandri A, Noseda E, Nannipieri F,
Saletu-Zyhlarz GM. Double-blind, placebo-controlled, multiple-ascending-dose
study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential
anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution
brain electromagnetic tomography). Neuropsychobiology. 2009;59(2):110-22. doi:
10.1159/000212380. PubMed PMID: 19365151.

2: Saletu-Zyhlarz GM, Anderer P, Wolzt M, Semlitsch HV, Assandri A, Nessi P,
Nannipieri F, Rosini S, Saletu B. Double-blind, placebo-controlled,
multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS
drug with potential anxiolytic activity. 1. EEG mapping, psychometric and
tolerability findings. Neuropsychobiology. 2009;59(2):100-9. doi:
10.1159/000212379. PubMed PMID: 19365150.

3: Anderer P, Saletu B, Wolzt M, Culic S, Assandri A, Nannipieri F, Rosini S,
Saletu-Zyhlarz GM. Double-blind, placebo-controlled, multiple-ascending-dose
study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and
cognition, utilizing event-related potential mapping and low-resolution brain
electromagnetic tomography. Hum Psychopharmacol. 2008 Apr;23(3):243-54. doi:
10.1002/hup.920. PubMed PMID: 18181252.